findmyKOL

Jessica Ailani, MD

Enriched profile

Professor in the Department of Neurology and Director of the MedStar Georgetown Headache Center · Georgetown University

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Washington, DC · Northeast · United StatesSpecialtyNeurologyFocusMigraine and Headache Studies+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Jessica Ailani is Professor in the Department of Neurology and Director of the MedStar Georgetown Headache Center at Georgetown University. OpenAlex indexes 213 publications with 5,446 citations (h-index 34); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.

Data verified 16 Oct 2026

Overview

Updated 16 Oct 2026

Jessica Ailani, MD, is Professor in the Department of Neurology and Director of the MedStar Georgetown Headache Center at Georgetown University. The public record shows 213 publications with 5,446 citations (h-index 34), centered on Migraine and Headache Studies, Intracranial Aneurysms: Treatment and Complications, Pain Mechanisms and Treatments. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 41 companies.

  • Most recent indexed publication: 2026 · Journal of comparative effectiveness research
  • Top research focus: Migraine and Headache Studies
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 41 companies

Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Migraine / Headache3 trialsPain1 trialHeadache1 trialForamen Ovale, Patent1 trial

Research focus

OpenAlex concept fingerprint
Migraine and Headache StudiesIntracranial Aneurysms: Treatment and ComplicationsPain Mechanisms and TreatmentsTemporomandibular Joint DisordersMusculoskeletal pain and rehabilitation

Drugs & molecules

across trials, industry payments and publications
Quliptageneric · AtogepantClinical trials—Industry payments151Publications4Ubrelvygeneric · UbrogepantClinical trials—Industry payments144Publications4Vyeptigeneric · EptinezumabClinical trials—Industry payments72Publications4RimegepantClinical trials—Industry payments52Publications1Trudhesageneric · DihydroergotamineClinical trials—Industry payments26Publications2Emgalitygeneric · GalcanezumabClinical trials—Industry payments18Publications2Aimoviggeneric · ErenumabClinical trials—Industry payments8Publications2Reyvowgeneric · LasmiditanClinical trials—Industry payments5Publications1Botoxgeneric · Botulinum toxin type AClinical trials—Industry payments148Publications—Nuplazidgeneric · PimavanserinClinical trials—Industry payments13Publications—Rytarygeneric · Carbidopa / levodopaClinical trials—Industry payments13Publications—Kynmobigeneric · ApomorphineClinical trials—Industry payments9Publications—

Works with

trial sponsors and companies reporting payments
Abbvie Inc.Clinical trials—Industry payments360Lundbeck LLCClinical trials—Industry payments57Pfizer Inc.Clinical trials—Industry payments46Allergan, Inc.Clinical trials—Industry payments40Lilly USA, LLCClinical trials—Industry payments35Impel Pharmaceuticals Inc.Clinical trials—Industry payments26H. Lundbeck A SClinical trials—Industry payments25ACADIA Pharmaceuticals IncClinical trials—Industry payments13Amneal Pharmaceuticals LLCClinical trials—Industry payments11Teva Pharmaceuticals USA, Inc.Clinical trials—Industry payments11Ge HealthcareClinical trials—Industry payments10Amgen Inc.Clinical trials—Industry payments9Eli Lilly and CompanyClinical trials—Industry payments8Merz Pharmaceuticals, LLCClinical trials—Industry payments8Axsome Therapeutics, Inc.Clinical trials—Industry payments7Sunovion Pharmaceuticals Inc.Clinical trials—Industry payments7Biohaven Pharmaceutical Holding Company Ltd.Clinical trials—Industry payments6Ipsen InnovationClinical trials—Industry payments6Avanir Pharmaceuticals, Inc.Clinical trials—Industry payments5BioDelivery Sciences International, Inc.Clinical trials—Industry payments5Eisai Inc.Clinical trials—Industry payments5Supernus Pharmaceuticals, Inc.Clinical trials—Industry payments5Adamas Pharmaceuticals, Inc.Clinical trials—Industry payments3Bausch Health US, LLCClinical trials—Industry payments3Biogen, Inc.Clinical trials—Industry payments3Biohaven Pharmaceuticals, Inc.Clinical trials—Industry payments3Neurocrine BioSciences, Inc.Clinical trials—Industry payments3Pfizer International LLCClinical trials—Industry payments3Tonix Medicines, Inc.Clinical trials—Industry payments3Abbott LaboratoriesClinical trials—Industry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
213publications

Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.

5,446citations

Total citations across indexed works.

34h-index

Hirsch index (OpenAlex). i10-index 73.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
41companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 16 Oct 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 16 Oct 2026

41 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Musculoskeletal

    80.6%
    Neuromuscular Blocker80.5%
    Onabotulinumtoxina100%Botox0%
    Part D + Part B<11 patients
    gamma-Aminobutyric Acid-ergic Agonist0.1%
    Baclofen100%
    Part D<11 patients

    + 2 more classes in this area

  • Nervous system

    19.3%
    Calcitonin Gene-related Peptide Antagonist17.8%
    Eptinezumab-jjmr100%
    Part B, office-administered≥12 patients
    Calcitonin gene-related peptide (CGRP) antagonists0.4%
    Aimovig Autoinjector71%Ajovy Autoinjector14%Emgality Pen14%
    Part D<11 patients

    + 7 more classes in this area

  • Metabolism & gastrointestinal

    0.1%
    Serotonin-3 Receptor Antagonist0.1%
    Ondansetron Odt100%
    Part D<11 patients
Where care is delivered (Part B)0.1% facility · 99.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 16 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 16 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Richard B. Lipton48David W. Dodick28Joel M. Trugman28Rashmi B. Halker Singh20Andrew M. Blumenfeld17Brett Dabruzzo16Stewart J. Tepper16Michelle Finnegan15Peter James Goadsby14Peter McAllister14Messoud Ashina13Sung Yun Yu13Carrie O. Dougherty12Jessica Cirillo11Pranav Gandhi11Amaal Jilani Starling11Matthew S. Robbins10Lucy Abraham10Anders Ettrup10Roger K. Cady10Paul K Winner10Lawrence Severt10Kaifeng Lu9Susan L. Hutchinson9Joshua M. Cohen8Patricia Pozo‐Rosich8Stephanie J. Nahas8Feng Dai8Annika Lindstén7Teshamae Monteith7Mette Krog Josiassen7Brad C. Klein7Rosa De Abreu Ferreira7Cristina Tassorelli7George Chakhava7Bjørn Sperling7Armin Szegedi7Lahar R. Mehta6Todd J. Schwedt6Dawn C. Buse6

Online presence

Updated 16 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/jessica-ailani-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    neurology.georgetown.edu/ailani

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurology.georgetown.edu ↗
  • Other

    practicalneurology.com/profiles/jessica-ailani-md-fahs-faan-fana/jQpZy9/biography

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →practicalneurology.com ↗
  • Other

    pri-med.com/globals/faculty/a/ailani-jessica

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pri-med.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 16 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • President-Elect

    American Headache Society Board of Directors

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →americanheadachesociety.org ↗
  • Member-at-Large

    American Headache Society Board

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurologylive.com ↗
  • Co-chair

    Practice Management Committee, American Headache Society

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurologylive.com ↗
  • Co-chair

    Next Generation Migraine Treatment Education Committee, American Headache Society

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurologylive.com ↗
  • Vice Chair

    Leadership Committee, American Headache Society

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neurologylive.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.